Preliminary Program


1- General

  • Biosimilars: Are rheumatologists and patients ready for transitioning patients from an originator to a biosimilar?
  • How to best manage osteoporosis in patients with arthritis.
  • How to deal with vaccination of patients with inflammatory arthritis.

2- Rheumatoid Arthritis

  • After cancer, which biologic should you use?
  • JAK inhibitors should be first line before biologic agents.
  • Pregnancy, biologics, and targeted synthetic disease-modifying antirheumatic drugs.
  • When is biologic monotherapy the treatment of choice?

3- Spondylarthropathies

  • Non-radiographic spondyloarthropathy: If you were paying for it, would you commence biologic therapy?
  • Psoriatic arthritis: How to balance management of the skin and the joints


  • Lupus and pregnancy: Good news for the doctor and the mother.


  • A disease of the bone/subchondral bone? Implication for treatment.
  • Inflammation in osteoarthritis as therapeutic target.
  • SYSADOA: Effectiveness in treating OA symptoms and maybe more.
  • Intraarticular therapy for osteoarthritis: Interesting new findings for patients.
  • Management of challenging osteoarthritis cases in daily practice: Well kept secrets.
  • Stem cells and other cellular therapies for osteoarthritis.